An evidence-led 2026 update on how single (GLP1), dual (GLP2) and triple (GLP3) incretin receptor agonists differ mechanistically in preclinical metabolic research.
Incretin biology has moved faster than almost any other area of peptide research over the past three years. What began as a single-receptor question — how does glucagon-like peptide-1 receptor (GLP-1R) activation influence glucose handling — has broadened into a comparative pharmacology problem involving at least three receptor systems and a growing family of engineered analogues. In this article we use neutral research code names for the compound classes: GLP1 for single receptor agonists, GLP2 for dual GIP/GLP-1 agonists, and GLP3 for triple GIP/GLP-1/glucagon agonists.
What current preclinical evidence says about mitochondrial-derived peptide MOTS-c and the cardiolipin-binding tetrapeptide SS-31 in ageing and metabolic-stress models.
A mechanistic comparison of the tripeptide KPV and Thymosin Alpha-1 across published inflammation, mucosal-barrier and immune-signalling research models.
Side-by-side mechanistic comparison of BPC-157 and TB-500 in tissue-repair research models, including receptor targets, delivery kinetics and typical study designs.
The science is international; the rules are not. These guides explain who regulates research materials in each market, where the research is done, and how local terminology differs.
How ipamorelin, a selective ghrelin-receptor agonist, and the GHRH analogue CJC-1295 are paired in growth-hormone pulse research, and what studies report.
One email a week from the lab, plus our Storage & Reconstitution guide sent instantly.
One-click unsubscribe in every email.
Verified suppliers
Where researchers source the compounds we cover
We are an independent publication — we sell nothing, hold no stock and take no payment. When you have finished reading, these are the suppliers we have checked for lot-matched third-party certificates of analysis.
1 · Plan the bench work
Work out reconstitution volumes and concentrations before ordering, so you buy the vial size your protocol actually needs.
Outbound supplier links are marked nofollow/sponsored. Compounds discussed are laboratory research reagents, not medicines. Listing is not an endorsement or medical advice.
Independent publication — we sell nothing. Supplier disclosure
Peptide Intel Hub is an independent educational publication. We are not affiliated with, owned by, or the same company as Biomech Peptides and Regena.app (biomechpeptides.com / regena.app). We do not sell, supply, ship or take payment for any compound. Because readers regularly ask where compounds discussed in published studies can be sourced for laboratory work, we list Biomech Peptides and Regena.app as suppliers we have verified and trust — every batch is released with a lot-matched third-party certificate of analysis (HPLC purity and mass-spectrometry identity). Outbound links are marked nofollow/sponsored and are provided to help readers, not to sell.
